NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: Update 2000

American Journal of Kidney Diseases

Volumn 37, Issue 1 SUPPL. 1, 2001, Pages

  Golper, T A ^a   Churchill, D ^a   Blake, P ^a   Burkart, J ^a   Chatoth, D K ^a   Firanek, C ^a   Geary, D ^a   Gotch, F ^a   Kliger, A S ^a   Korbet, S M ^a   Tzamaloukas, A ^a   Warady, B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

BLOOD SAMPLING; BODY MASS; CREATININE CLEARANCE; DIALYSATE; DOSE CALCULATION; FOLLOW UP; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALNUTRITION; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SURVIVAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; URINALYSIS;

EID: 0035156729     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure
2. The USRDS dialysis morbidity and mortality study 1 (Wave 1)
3. Relationship between GFR and nutritional status - Results from the MDRD study
4. Protein intake in renal disease
5. Spontaneous dietary protein intake during progression of chronic renal failure
6. Correlation between urea reduction rates and serum albumin levels in patients on hemodialysis
7. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
8. Initiation of dialysis
9. Late referral for maintenance dialysis
10. An analysis of the adequacy of preparation for end-stage renal disease care in Michigan
11. Detrimental effects of late referral in patients with chronic renal failure: A case control study
12. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist
13. Chronic renal failure: Factors influencing nephrology referral
14. Effects of the dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study
15. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
16. Reproducibility of studies of peritoneal dialysis adequacy
17. Peritoneal equilibration tests
18. Peritoneal membrane transport function in children receiving long-term dialysis
19. Changes in peritoneal transport during the first month of peritoneal dialysis
20. Rapid decline of residual renal function in patients on automated peritoneal dialysis
21. Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis
22. A more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation
23. The measured creatinine generation rate in CAPD suggests only 78% of prescribed dialysis is delivered
24. A prospective study of the effect of noncompliance on small solute removal in continuous ambulatory peritoneal dialysis
25. Assessing compliance with the dialysis prescription in children on peritoneal dialysis
26. Creatinine generation rate and lean body mass: A critical analysis in peritoneal dialysis patients
27. A proposed mechanism for reduced creatinine excretion in severe chronic renal failure
28. Prediction of creatinine clearance from serum creatinine
29. Compliances with the peritoneal dialysis prescription is poor
30. Predicted and measured daily creatinine production in CAPD: Identifying noncompliance
31. Estimated versus predicted creatinine generation as an indicator of compliance with the prescribed dose of continuous peritoneal dialysis
32. Comparison of measured and predicted creatinine excretion is an unreliable index of compliance in PD patients
33. Can an excess of estimated over-predicted creatinine generation be a discriminating test for non-compliance in continuous ambulatory peritoneal dialysis?
34. An elevated ratio of measured to predicted creatinine production in CAPD patients is not a sensitive predictor of noncompliance with the dialysis prescription
35. Pharmokinetic analysis of creatinine generation discrepancy as an index of noncompliance in CAPD
36. How reproducible is daily creatinine recovery in chronic peritoneal dialysis
37. Total body water volumes for adult males and females estimated from simple anthropometric measurements
38. Relationship between total body water and surface area in normal and obese subjects
39. The assessment of body water and fatness from infancy to adulthood
40. A formula to estimate the approximate surface area of height and weight be known
41. Estimation of human body surface area from height and weight
42. Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adults
43. Estimating the surface area of the human body
44. Volume of distribution and fractional clearance of urea in amputees on continuous ambulatory peritoneal dialysis
45. Creatinine clearance in amputees on CPD
46. An analysis of the determinants of urinary urea and creatinine clearance in patients on continuous peritoneal dialysis
47. A longitudinal, five year survey of urea kinetic parameters in CAPD patients
48. Canada-USA (CANUSA) multicentre study of peritoneal dialysis adequacy: Description of the study population and preliminary results
49. Adequacy of continuous ambulatory peritoneal dialysis: Morbidity and mortality in chronic peritoneal dialysis
50. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients
51. Correlation of normalized protein catabolic rate to weekly creatinine clearance and KT/V in patients on peritoneal dialysis
52. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis
53. Protein catabolic rate in patients on continuous peritoneal dialysis: A multivariate predictive model
54. Urea kinetic modelling exaggerates the relationship between nutrition and dialysis in CAPD patients. (The hazards of cross-sectional analysis)
55. Serum albumin in continuous peritoneal dialysis: Its predictors and relationship to urea clearance
56. A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients
57. Which comes first, Kt/V or PCR-chicken or egg?
58. A proposed glossary for dialysis kinetics
59. Calculation of protein equivalent of total nitrogen appearance from urea appearance: Which formulas should be used?
60. Lean body mass estimation by creatinine kinetics
61. Urinary creatinine excretion and lean body mass
62. Lean body mass estimation by creatinine kinetics, bioimpedance, and dual energy x-ray absorptiometry in patients on continuous ambulatory peritoneal dialysis
63. Creatinine clearance in continuous peritoneal dialysis: Dialysis dose required for a minimal acceptable level
64. The minimal dose of dialysis required for a target KT/V in continuous peritoneal dialysis
65. A proposed glossary for dialysis kinetics
66. Nitrogen balance during intermittent dialysis therapy of uremia
67. Protein catabolic rate calculations in CAPD patients
68. Protein intake and urea and nitrogen appearance in stable pediatric PD patients
69. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients
70. Peritoneal transplant properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis
71. Dietary prescription based on estimated nitrogen balance during peritoneal dialysis
72. Kinetic modeling in hemodialysis
73. Kinetic modelling in peritoneal dialysis
74. The effect of changes in dialysate volume on glucose and urea equilibration
75. A prescription model for peritoneal dialysis
76. Coinvestigators for the Fresenius Randomised Dialysis Prescriptions and Clinical Outcome Study (RDP/CO): Computerized urea kinetic modeling (UKM) to prescribe and monitor delivered Kt/V (pKt/V, dkT/V) in peritoneal dialysis
77. Peritoneal dialysis in kinetic modeling: Validation in a multicenter clinical study
78. A multinational clinical validation study of PD Adequest 2.0
79. Estimation of peritoneal mass transport by three-pore model in children
80. The use of the PD adequest mathematical model in pediatric patients on chronic peritoneal dialysis
81. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study
82. Urea kinetic modeling is an appropriate assessment of adequacy
83. Clinical value of standardized equilibration tests in CAPD patients
84. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis
85. The effect of body position (P), surface area (BSA), fill volume and intraperitoneal exchange volume (Vip) on the peritoneal transport constant
86. Changes in peritoneal membrane transport rates in patients on long term CAPD
87. Kinetic modeling as a prescription aid in peritoneal dialysis
88. Clinical evaluation of a peritoneal dialysis kinetic modeling set
89. Mass transfer properties of the human peritoneum
90. A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory dialysis
91. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
92. The incident of patient cohort study design with uncontrolled dose may result in a substantial overestimation of mortality (M) as a function of peritoneal dialysis (PD) dose
93. Effectiveness of renal fellowship training for subsequent clinical practice
94. Prospective, multicenter evaluation of patient transfer from PD to HD in 1995
95. Relationship of dose of hemodialysis and cause-specific mortality
96. The predictive value of KT/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present
97. Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis
98. Maintaining adequacy in CAPD by individualizing the dialysis prescription
99. Prognostic factors in CAPD patients: A retrospective study of a 10-year period
100. Formal assessment of quality of life instruments for end-stage renal disease
101. Monitoring dialysis patients' health status
102. Development of a quality life measure for renal dialysis patients
103. Choices for healthy outcomes in caring for end-stage renal disease
104. Development of the kidney disease quality of life (KDQUOL) instrument
105. Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers
106. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on a patient survival
107. Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics
108. CAPD adequacy and dialysis morbidity: Detrimental effect of a high peritoneal equilibriation rate
109. Serum albumin in patients on continuous ambulatory peritoneal dialysis: Predictors and correlations with outcomes
110. Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis
111. Adequacy of continuous ambulatory peritoneal analysis: Comparison with other dialysis techniques
112. Relationships between dialysis quantification and normalized protein catabolic rate in peritoneal dialysis
113. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients
114. The correlation between Kt/V and protein catabolic rate - A self-fulfilling prophecy
115. Limitations of kinetic models as predictors of nutritional and dialysis adequacy in continuous ambulatory peritoneal dialysis patients
116. Nutritional management of pediatric patients on chronic dialysis
117. Nutritional status of children undergoing continuous ambulatory peritoneal dialysis
118. Morbidity and mortality of CAPD and hemodialysis
119. Indications for dialysis
120. Peritoneal dialysis in diabetics
121. Treatment modality selection in 150 consecutive patients starting ESRD therapy
122. Dialysate Leaks
123. Non-renal indications for peritoneal dialysis
124. Peritoneal dialysis in refractory congestive heart failure. Part II. Continuous ambulatory peritoneal dialysis (CAPD)
125. Successful use of continuous ambulatory peritoneal dialysis in refractory heart failure
126. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis
127. Continuous ambulatory peritoneal dialysis as a treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases
128. CAPD: A successful treatment in patients suffering from therapy-resistant congestive heart failure
129. PD treatment for severe congestive heart failure
130. Hand gangrene in diabetics on chronic dialysis
131. When should chronic peritoneal dialysis be recommended over hemodialysis?
132. The process of prescribing CAPD
133. Peritoneal membrane failure: Differential diagnosis, evaluation, and treatment
134. Is chronic peritoneal dialysis safe in patients with intrabdominal prosthetic vascular graphs?
135. Continuous ambulatory peritoneal dialysis after abdominal aortic graft surgery
136. Effective continuous ambulatory peritoneal dialysis following abdominal aortic aneurysm repair
137. Weight limitations for weekly urea clearances using various exchange volumes in continuous ambulatory peritoneal dialysis
138. Continuous peritoneal dialysis in heavyweight individuals: Urea and creatinine clearances
139. Careful patient selection and dialysis prescription are required for effective nightly intermittent peritoneal dialysis
140. Symptomatic fluid retention in patients on continuous peritoneal dialysis
141. Investigation and management of ultra-filtration failure in CAPD